This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk07: Thank you for standing by. This is the conference operator. Welcome to the Abbott Brands third quarter fiscal 2023 results conference call. As a reminder, all participants are in listen only mode and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. To join the question queue, you may press star then one on your telephone keypad. Should you need assistance during the conference call, you may signal an operator by pressing star and then zero. I would now like to turn the conference over to Alyssa Berry, Investor Relations. Please go ahead.
spk06: Thank you, operator, and good afternoon, everyone. Welcome and thank you for joining Avant Brand's Q3 Fiscal 2023 Results Conference Call. My name is Alyssa Berry, Investor Relations for Avant. Speaking on our call today is Avant's founder and CEO, Norton Singhaven. and Chief Financial Officer Miguel Martinez. Avant's Chief Operating Officer David Lin is also present and will be participating in our Q&A session. Our Q3 2023 results were disseminated yesterday and are available on CNR Plus and on our website at www.avantbrands.ca. Before we get started, I wish to remind everyone that some statements made on today's call are forward-looking in nature and therefore are subject to certain risks and uncertainties, which are all outlined in detail in our regulatory filings available on CDAR+. On this call, we will refer to the company as Avant Brands or Avant. I will now turn the discussion over to Miguel to share the company's financial highlights. Norton will then provide a strategy update. Please go ahead, Miguel.
spk02: Thank you, Alyssa, and good afternoon, everyone. Thank you for joining us today. We are pleased to report another strong quarter for Avant Brands. In Q3 2023, we continued our trend of delivering positive year-over-year sales growth and achieved several significant milestones. Diving into some of our key financial metrics for the third quarter ended August 31, 2023. We reported gross revenues of $7.5 million, representing a 61% increase compared to Q3 last year. This also represents our fifth consecutive quarter of positive cash flow from operations, reinforcing our commitment to sustainable growth. Our overall weighted average net selling price of $4.17 reflects changes in the recreational sales product mix and some out of spec sales in the export business to business market. While we continue to hold pricing for the company's flagship black market brands, as well as high margin flower sales internationally. Our cash flow from operations after changes in non-cash working capital was $1.8 million, demonstrating our ability to generate positive cash flow consistently. Successful integration of flour into our cultivation framework in February 2023 contributed significantly to the growth of our gross revenue margin, adjusted EBITDA and cash flow from operations. This is a significant achievement with only six months of completing the acquisition. And we anticipate that over the coming quarters, flour will generate meaningful cash flows to the event group of companies. Corporate overhead, net of depreciation and share based compensation was $2.9 million for the quarter and $6.9 million year-to-date, which is a 75% and 40% increase over the prior year comparative period, respectively. This increase is primarily due to growth initiatives, increased regulatory fees, performance bonuses, and estimated professional and audit fees. We continue to look at all aspects of our business to stay lean and efficient. And finally, we achieved an adjusted EBITDA of $900,000 for the quarter with an adjusted EBITDA margin of 14%. During the quarter, the company also secured a $3.5 million credit facility to ensure that Avant remains capitalized as we bridge to stronger future cash flows. As of August 31st, we had drawn down $2 million on the facility, and we currently have $1.5 million remaining. With that, I will turn the call over to our CEO and founder, Norton Singhaven, to expand on our operations and provide an update on strategic initiatives.
spk03: Thank you, Miguel. We produced a record-breaking 3,268 kilograms of cannabis in Q3 of 2023, representing a significantly increased run rate, which will help enable us to achieve higher levels of quarterly sales in the near future. Our efforts to optimize output and quality while concurrently reducing costs is starting to have a positive impact on our cash flows. This quarter, we experienced a production increase as a result of the successful integration of flour, and increasing our capacity utilization company-wide to 65% versus 46% in the previous quarter. This resulted in an unprecedented surge in production for us. The inventory buildup is essentially a timing issue and is not indicative of demand. Rather, we are preparing our products to be delivered into Ontario, Quebec, and internationally. We expect to see this reflected in our results next quarter. It is also important to note that a significant portion of our inventory buildup consists of popcorn and shrimp. which is what we use for concentrates and pre-rolls. Currently our velocity and demand for pre-rolls and concentrates doesn't match the rate where we accumulate our popcorn and trim. We're currently working on initiatives to launch new products and potentially export some of our smaller bud flower. Avant has achieved 65% capacity utilization while dramatically lowering operating costs at the facility level and maintaining high quality standards. We embrace a philosophy of continuous improvement Thus, we expect to make additional improvements in future quarters. Our cost-saving initiatives have played a pivotal role in enhancing our gross margins, even in the face of price compression and inflation in the Canadian recreational market. This quarter, our overall gross margins stood at 31%, a testament to our commitment to financial discipline. Rec gross margin was an impressive 39%, while our export gross margin was 16%. The export margin was driven down as we continued to liquidate Flowers' inventory we inherited from the acquisition that closed earlier this year. I'm also happy to announce that we recently expanded our international client portfolio with a focus on Israel, Australia, and Germany. We executed agreements with new clients in such markets with a view to increasing the company's total export revenue while achieving geographic and customer diversification. Lastly, we have commenced our first shipments to Quebec for black market flour and free roll skews. This marks a great milestone for Avant as we are confident that Quebec will be a successful market for our products and brands. Our solid financial results coincide with the continued high demand for our products, both domestically and globally. Building and maintaining our strong brand recognition continues to drive our growth. We are proud to highlight that Avant currently ranks as the 10th largest publicly traded LP in Canada by market cap. Avant was also ranked 49th out of 425 on the global males list of Canada's top growing companies for 2023, which is sector agnostic. At 849% growth over its last three years, the list did not include any public or private licensed producers, placing Avant as the fastest growing licensed producer in the country on this list. In the face of a difficult market landscape, Avant is determined to create long-term value for its shareholders and establish itself as a leading premium cannabis company. As we continue to tell our story to the investment community, our key differentiators remain the same, including our ability to produce premium cannabis flower at scale, which based on what we see, no other LPs have replicated what we have accomplished at the level of quality and scale that we have. We will continue to have a strong focus on cost savings, operational efficiency, aggressive pursuit of new markets, and of course, our strong brand position. Avon stands out in a sector that has seen its fair share of challenges not to mention the state of overall equity markets. We have diligently navigated this, demonstrating resilience and adaptability, which sets us apart. With a strong commitment to excellence, we are confident in our long-term success and solid positioning within our sector. As of the end of last week's trading, Avon currently sits as the second best performing Canadian stock year to date at a 12% gain, while the average is at a 26% loss. We understand this is still nothing for shareholders to be excited about as we experience a bear market further exacerbated with the vast majority of Canadian cannabis companies struggling. We remain extremely dedicated to generating long-term shareholder value and are confident as we continue to execute, generate positive cash flow, fulfill our vendor take-back obligations, that eventually we will deliver substantial value to our loyal and dedicated shareholders. In closing, I'm proud that we are the 49th fastest growing company in this country. We are the 10th largest publicly traded LP. We are the largest indoor producer in this country and the second best performing Canadian cannabis stock in this country. Thank you for your continued support and interest in Avant Brands. Now we will open up the floor to questions.
spk07: We will now begin the question and answer session. To join the question queue, you may press star then one on your telephone keypad. You will hear a tone acknowledging your request. If you are using a speakerphone, please pick up your handset before pressing any keys. To withdraw your question, please press star then two. We will pause for a moment as callers join the queue. The first question comes from Jordan Key, a private investor. Please go ahead.
spk04: Hey, Nora. Jordan here. How's it going? Hey, good, good. How are you? Yeah, I'm doing okay. Crazy times out there. I was glad to hear that everyone's doing okay after all those fires that they're in Kelowna. Definitely. Interesting quarter. Some numbers kind of wanted to run by you. The credit facility is drawn down 2 million now, so there's 1.5 million left. Do you think that you're going to need to draw down the other 1.5 million? And this kind of jumps into my next question, which is going to be, you know, how are you looking at Q4?
spk03: I'll let Miguel take the credit facility one.
spk02: Hi. Yes, we plan to draw down on the remaining 1.5 during Q4.
spk04: Okay. And, Nor, does that mean you've got visibility into Q4 and it's not going to be one where the company generates enough cash flow to pay its obligations? We'll let Miguel take that one also.
spk02: To give you a little bit more context around the drawdown, we have our convertible to venture and a promissory note with MENA, and those two facilities will be paid down with the drawdown of this loan.
spk03: So, Jordan, we have a payment due to the vendors of F20 November 1st for a 1.6 and some change. Mm-hmm. Then we have $720,000 due to MENA for the flower bio due December 12th. So it's going to be obviously draining a significant portion of our cash between November and December. That's why we intend to draw down the credit facility. The good news is after that, MENA is completely repaid, so that obligation is off the books. And we have another three months until our next payment is due to the vendors of F-20.
spk04: Okay. Yeah. And the credit facility just, and Miguel, sorry, I didn't introduce myself. I missed your last call and that's my fault. But, you know, we've talked about in the past that, you know, with the modeling that you guys had done originally, you didn't think that you'd need a credit facility. But now the credit facility is essentially being used to pay down these obligations and I would assume kickback payments. So when does the credit facility have to be paid back? And is there a balloon at the end?
spk03: The credit facility, if I'm correct, is amortized over three years.
spk04: So do payments start immediately on it? Or does it balloon?
spk02: We're currently making payments on the $2 million that's been drawn.
spk03: Got it. It basically operates like a term loan. As soon as you draw down on it, it starts amortizing. It starts amortizing. Okay.
spk04: Yeah. So that makes sense. It essentially makes a short-term obligation into a longer-term obligation over the three years.
spk03: Correct. And there's no balloon at the end. It's nice that we're just chipping away at it monthly. Okay.
spk04: That sounds good. Can I ask one more thing about the balance sheet? So for the last few quarters, we've been seeing some numbers. Let's just call it $14 million, $15 million in inventory numbers. And then when earnings come out, we're seeing numbers that are far less than inventory. And like, I know the 60 days and everything like that. But how is that translating? Is that because things are getting kicked back? Is that because the way that reporting is required, that it's not really, you know, the amount of actual inventory you're going to sell? Any context on that would be super helpful.
spk02: Absolutely. So some context I can provide you with inventory in general. is because we're an agriculture company, we have an agriculture product, the biological asset does make our inventory balance higher than our cost base. And so while we are expanding our production and we are developing new brands and new products and facilitating new customers, meeting new customers, signing new agreements and expanding internationally, we also, the value on the balance sheet in inventory Roughly speaking is about 40% of it is biological asset, fair value amounts, not really to do with the hard cost of our production.
spk04: But that's broken down into a separate line item on the balance sheet. So you're saying there's biological assets are represented twice, both as biological assets and as inventory?
spk02: Not twice. There's the biological asset of the plant that's growing, which is a separate line item. So that's the living plant in the facility measured at fair value, less cost to sell. The inventory on the balance sheet at the time of harvest, the fair value, less cost to sell becomes your inventory cost base. And so there's the two line items, the biological asset of the living plant, and then in inventory is our production. And that production has a cost base of fair value, less cost to sell. And so it is in two places on our financial statement, I guess is the easiest way to answer that question. They transfer from the living plant into inventory at the new cost base.
spk04: Okay. So you're saying if I'm looking at an inventory number, let's just call it 20 million, right, in inventory, you're saying that actually only 60% of that is going to be sold and will result in money.
spk02: No, I'm not saying 60% of it's going to be sold. I'm saying 60% of it is our cash cost of inventory with depreciation. The other 40% is approximately, these are approximate numbers, but the other 40% approximately is fair value amounts from the biological asset standard under IFRS. On the P&L, you can see the impact of these because our margin is separated out into two different components. And so the margin on the P&L, you can see revenue less cost of sales, and that cost of sales line is reflective of what you would traditionally expect to see in cost of sales, the cost of our production plus depreciation. And then it says gross margin before fair value changes, and it talks about the – or it notes two line items there, the realized gain on changes in fair value of biological assets, which is reflective of the change in value of a biological asset line on the balance sheet, as well as a change in fair value of biological assets realized through inventory sold. And so we've separated out within inventory, there's the cost and the fair value component. The cost, when inventory is sold, the cost goes to cost of sales. And the fair value component goes to change in fair value of biological assets realized through inventory sold. I appreciate it's a somewhat confusing topic, but it's the interest.
spk04: Yeah, maybe that's not the piece to hang my hat on. I guess if we look just at the production though, right? So I think, and using rough numbers here so nobody quote me, about 3,600 kgs produced in Q3. It was about 2,000 produced in Q2 with an average selling price, right, per gram. And I think that includes trim of, what, 450, something along those lines. Then wouldn't you, theoretically, you would expect the production of those two quarters to produce somewhere like $20 million in revenue? Yeah.
spk03: Not necessarily because part of that makes up for popcorn and trim, and part of that is just because something is classified in inventory doesn't mean it's ready for sale, right? You've got to do your testing, you've got to package it, and you've got to ship it out the door. And some of the product is slated aside for a delivery date, call it in October or November. So, you know, a simplest way to put it is out of 100 kg, and I think I told you this before, Probably about 60 kg of that is going to be what we call our high-grade ultra-premium flour. We're left with another 40%. That's going to be popcorn and trim. So as we mentioned in the press release and as I mentioned in kind of my summary, we are accumulating popcorn and trim at a rate higher than what our velocity is to move it, right? But that's not our core business. Our core business isn't to make concentrates with popcorn and trim. so happens that our size and scale that we're starting to accumulate that. So a lot of that inventory, I don't know what the exact number is. If you broke it down, it's going to be in progress lots of call it the 60% grade A product, top shelf product that's destined for a consumer. And then the balance is essentially accumulating popcorn and shrimp. There isn't a glut of what I call top grade flour that's sitting there accumulating that we don't have a home for. If that's what you're getting at, which I think is what you're getting at.
spk04: Well, what I'm really getting at, and probably it's challenging to answer on the phone, which is when are we going to see the real ramp, you know, with flour and revenue, right? Because we saw, you know, fairly substantial quarters prior to flour being acquired, right? And either upwards of eight, nine million. And so when you're thinking about flour being acquired and flour being, you know, It's a large facility. You're thinking, oh, OK, well, maybe we're talking about 13, 14 million dollar quarters here at some point. And we're just not seeing that yet. So that's that's what I was really trying to get at.
spk01: Hi, it's David here. I think your basic point is valid, though. We don't want to make a forward looking statement about, you know, specific quarters in the future. But if you're asking whether that higher level of production enables us to achieve higher levels of sales going forward, the answer is absolutely yes. That's what we're working towards. And with flour not only coming on stream but producing at a very significant rate, the largest facility in our family, it will enable us to achieve higher levels of sales in future quarters, just that we don't want to make a specific statement as to which quarter will be the first one when you see that happen.
spk04: Okay, I got you. And did the Desjardins claim, did that go away? I didn't see it anywhere in the reporting.
spk03: Desjardins claim? No, it is still in progress and there hasn't been any updates since. This will be drawn out. It'll be something for a couple of years along with the MacArthur claim that we're dealing with. Did they file a lawsuit or is it just a letter?
spk04: They filed a statement of claim. I don't know what that is in Canada, but I was just curious what was resolved. It doesn't sound like it is. All right. Let me drop for now. If it comes back around in line, I'll ask more questions. I appreciate you guys so much answering my questions and Good luck on the future quarters. Hopefully, things ramp up here soon.
spk03: Thanks.
spk07: Once again, if you have a question, please press star, then one. The next question comes from Rahim Rahman, a private investor. Please go ahead.
spk05: Hi, Norton, Miguel, and the team. Thanks for another successful quarter. I just had a question regarding, so just to compare before the flower acquisition took place, some industry pundits made disparaging remarks. It was whether that was a strategic decision to begin with. I remember maybe it was Rob McPherson who categorized it quite colorfully as a bag of poopy pops. While acknowledging that McPherson has never actually worked in the industry. Um, could you guys just reconcile that perspective considering a really good quarter in terms of the acquisition?
spk03: Yeah. First of all, you know, somebody on LinkedIn type in a way who's never worked a single second in cannabis, his opinion, I don't really hold in high regard, but I do respect the fact that he has a CPG background. But I think, um, You know, cannabis is fast-moving. It's a startup. There's no precedent, and it's very entrepreneurial-driven and consumer-focused, whereas Mr. Bag of Poopy Lollipops or whatever comes from large global corporate CPG. But I agree with a lot of his points, to be honest, and I've followed him on LinkedIn extensively until he decided to block me, and I agree with most of his opinions, especially on the industry. But Yeah, when he said that the flour acquisition was a bag of poopy pops, I think this quarter, whether we close on this in February 1st and call it by August 31st, we would say flour is on track to be extremely successful. We worked very closely with the management team and operations team at flour. even before we took full legal ownership, to have a quick turnaround in the business. We increased our output dramatically. We eliminated millions of dollars in operating costs, even though when we took over, they said, this thing has been stripped to the bones. You're not going to find much savings. We just want to set the stage so you guys have reasonable expectations. Don't go in there thinking you're going to find $6 million within weeks, right? But, you know, we found, you know, single digit million, close to two, I believe, within weeks. And you know what? We're staying focused on producing high-quality flour out of there. So now, come today, that bag of poopy pops is generating positive cash flow for our company. It's accounted for 46% of our total harvest in Q3, and we're extremely happy with the integration. I think long-term shareholders are going to see the contribution that flour contributes to our company, and it's a massive milestone, in my opinion, for our company. Flour has made us, if I'm correct, the largest indoor producer in the country now.
spk05: That's amazing. Thanks for that comprehensive response. And just on the specific timing issue that led to the production outpacing sales, again, could you shed some light on that, whether that's normal, it's above cyclical, or...
spk03: Yeah, I think it's completely normal. I think in any sort of manufacturing or production, and I really like Miguel's example when he uses this, but I mean, if you were producing cows, I mean, you're not selling your steaks right away, right? And furthermore, the other example that I really respect is that we're producing the high-end porterhouses when we still have the other byproduct, which is our popcorn and trim that we need to move, right? So As I said multiple times, it's in our press release, it's in my initial thoughts and summaries of this call that we're not experiencing any sort of significant demand challenges for our products. Everything still has a home. Lots are identified and lots have an identified customer for them months in advance through our production planning and sales planning. So as it stands, it's just simply delays or deliveries for October or November, right? We harvest something in July or August, and that is meant to be delivered for a customer in the following quarter, and that's just part of business.
spk05: Awesome. Thanks a lot. I hope you guys continue being the awesome machine that you guys are.
spk00: Thank you.
spk07: The next question comes from Jordan Key, a private investor. Please go ahead.
spk04: Welcome back. Hey, thank you. I thought there'd be a few more people on the line because last quarter's was so busy. So quickly, Nort, are you guys thinking about the potential rescheduling in the United States and how that impacts both sales in Canada, United States, and around the world? And if you do have anything you're able to share about that, anything worthwhile to talk about there?
spk03: To be honest, we mainly focus on just what's going on in the market we compete in. And we don't even pay much attention to some of the other Canadian companies that aren't relevant to us, right? We keep tabs on the guys that are playing the categories that we play in. Now, answering this question personally, I do like the U.S. market. I think it's going to be a huge opportunity for companies that I think have their shit together, right? Does Avant want to go and aggressively tackle U.S. if this were to happen in the next six months? I don't think so. But long term, listen, like we're tackling markets way further than U.S. We're going aggressively after Germany, Israel, Australia. We're eyeing the U.K. So I think if the opportunity presented itself and depending where we were with our priorities, I don't think the U.S. is out of the question. So I think any geographical country is a possibility for us.
spk00: Awesome, Nord. Thank you. That's all. Once again, if you have a question, please press star, then 1.
spk07: There are currently no more questions in queue, and this concludes the question and answer session. I would like to turn the conference back over to Norton Singhaven for any closing remarks.
spk03: Thank you again, everyone, for joining us today. If you have any questions or would like to connect with us, please reach out to us anytime. Have a great day.
spk07: This concludes today's conference call. You may disconnect your lines. Thank you for participating and have a pleasant day.
Disclaimer